SCHEMBL9201406

SCHEMBL9201406

CCOC1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 5/20 0.64
PRKCA P17252 7/20 0.62
CDK4 P11802 9/20 0.61
CCND1 P24385 9/20 0.61
PRKD3 O94806 4/20 0.61
PRKCG P05129 4/20 0.61
PRKCB P05771 4/20 0.61
PRKCH P24723 4/20 0.61
PRKCI P41743 4/20 0.61
PRKCE Q02156 4/20 0.61
PRKCQ Q04759 4/20 0.61
PRKCZ Q05513 4/20 0.61
PRKCD Q05655 4/20 0.61
PRKD1 Q15139 4/20 0.61
PRKACA P17612 3/20 0.61
PRKACG P22612 3/20 0.61
PRKACB P22694 3/20 0.61
CAMK2B Q13554 6/20 0.50
CAMK2G Q13555 6/20 0.50
CAMK2D Q13557 6/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22765176 0.86 PRKCA (0.80) ROCK2PRKCACDK4CCND1PRKD3
SCHEMBL9196626 0.76 CDK4 (1.00) ROCK2PRKCACDK4CCND1PRKD3
SCHEMBL24853081 0.70 PRKCA (0.58) ROCK2PRKCACDK4CCND1PRKD3
Staurosporine Aglycon SCHEMBL8124103 0.68 CDK4 (1.00) ROCK2PRKCACDK4CCND1PRKD3
Staurosporine Aglycon SCHEMBL30530825 0.68 CDK4 (1.00) ROCK2PRKCACDK4CCND1PRKD3
Staurosporine Aglycon SCHEMBL29406635 0.68 CDK4 (1.00) ROCK2PRKCACDK4CCND1PRKD3
SCHEMBL14525822 0.65 CDK4 (0.58) ROCK2PRKCACDK4CCND1PRKD3
SCHEMBL5438544 0.65 PRKCA (0.71) ROCK2PRKCACDK4CCND1PRKD3
SCHEMBL12845915 0.64 CDK4 (0.64) PRKCACDK4CCND1PRKD3PRKCG
SCHEMBL14708731 0.63 CDK4 (0.80) ROCK2PRKCACDK4CCND1PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993024490-A1 USE OF INDOLOCARBAZOLS IN AIDS TREATMENT Gödecke Aktiengesellschaft (DE) 1993-12-09 WO claimed
US-5438050-A Indolocarbazole derivatives, processes for their preparation and compositions containing them GODECKE AKTIENGESELLSCHAFT (DE) 1995-08-01 US disclosed
EP-0328000-B1 Indolocarbazole derivatives, process for their preparation and medicines containing same GOEDECKE AG (DE) 1995-01-18 EP disclosed
WO-1993024490-A1 USE OF INDOLOCARBAZOLS IN AIDS TREATMENT Gödecke Aktiengesellschaft (DE) 1993-12-09 WO disclosed
EP-0328000-A2 Indolocarbazole derivatives, process for their preparation and medicines containing same GÖDECKE AKTIENGESELLSCHAFT (DE) 1989-08-16 EP disclosed